Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 71.9% in March

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 134,600 shares, an increase of 71.9% from the February 28th total of 78,300 shares. Currently, 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 2,000 shares, the days-to-cover ratio is presently 67.3 days.

Oxford Biomedica Price Performance

OXBDF remained flat at $3.88 during midday trading on Friday. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. The company has a 50 day moving average of $4.49 and a two-hundred day moving average of $4.92. Oxford Biomedica has a 52 week low of $2.44 and a 52 week high of $5.68.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.